Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01963780 · ClinicalTrials.gov registry record · NA

International EXPAND Lung Pivotal Trial

A NA study, sponsored by TransMedics.

Completed
Registry status
NA
Development phase
79
Enrollment target

NCT01963780: Completed NA study, sponsored by TransMedics.

NCT01963780 is a NA study that has completed, run by TransMedics. The registered enrollment target is 79 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01963780, a NA study, has completed, sponsored by TransMedics.

COMPLETED
Registry status
NA
Development phase
79 participants
Enrollment target

Study Summary

To evaluate the safety and effectiveness of the OCS™ Lung to recruit, preserve and assess donor lungs that may not meet current standard donor lung acceptance criteria for transplantation.

Primary Outcome

Primary graft dysfunction is graded on a scale of 0 to 3 according to the 2005 ISHLT PGD grading consensus. Grade 0 is considered the least severe and grade 3 is considered a more severe outcome.

Interventions

  • DEVICE OCS Lung Preservation

Trial Details

FieldValue
Enrollment Target 79 participants
Start Date 2013-11
Est. Completion 2018-04
Phase NA
TransMedics

23 total trials

What the finished NCT01963780 record still lists

NCT01963780 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 79 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower).

The record links to 0 conditions, and to 1 intervention - of which OCS Lung Preservation is the first listed.

NCT01963780 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01963780 about?

NCT01963780 is a clinical study titled "International EXPAND Lung Pivotal Trial". To evaluate the safety and effectiveness of the OCS™ Lung to recruit, preserve and assess donor lungs that may not meet current standard donor lung acceptance criteria for transplantation.

What is the current status of trial NCT01963780?

This trial is currently completed. It is a NA study. The enrollment target is 79 participants. The study started on 2013-11. Estimated completion is 2018-04.

What interventions are being tested in trial NCT01963780?

The interventions under investigation include: OCS Lung Preservation (DEVICE).

Who is sponsoring clinical trial NCT01963780?

This trial is sponsored by TransMedics, which has 23 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01963780's enrollment target sits among peer trials

79 1060th of 2000 higher than 941 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05798897 · 79 participants · Phase 1

    Safety and Preliminary Efficacy of MT-601 in Patients With Relapsed/Refractory Lymphoma

  • NCT06042439 · 79 participants · NA

    AM vs PM Exercise Training

  • NCT06223555 · 79 participants · NA

    Variability In Mixed Meal Tests: Fixed Versus Adjusted to Energy Needs Caloric Dose

  • NCT01243931 · 80 participants · NA

    Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01963780, the US trial registry maintained by the National Library of Medicine. NCT01963780 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.